Normal view MARC view ISBD view

Clonidine treatment for hallucinogen persisting perception disorder. [electronic resource]

By:

Lerner, A G

Contributor(s):

Producer: 19981020Description: 1460 p. digitalISSN:

0002-953X

Subject(s):

Online resources:

Available from publisher's website

In: The American journal of psychiatry vol. 155

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Case Reports; Letter

There are no comments on this title.

to post a comment.

Previous

Back to results

Next

1
2
3
4
5

1 Bioavailability of generic ritonavir and lopinavir/ritonavir tablet products in a dog model.
by Garren, Kevin W
2 Economic modeling of the combined effects of HIV-disease, cholesterol and lipoatrophy based on ACTG 5142 trial data.
by Simpson, Kit N
3 Initial viral decay to assess the relative antiretroviral potency of protease inhibitor-sparing, nonnucleoside reverse transcriptase inhibitor-sparing, and nucleoside reverse transcriptase inhibitor-sparing regimens for first-line therapy of HIV infection.
by Haubrich, Richard H
4 Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment.
by Haubrich, Richard H
5 Class-sparing regimens for initial treatment of HIV-1 infection.
by Riddler, Sharon A

Close